Peter S. Brzovic

Peter S. Brzovic

Auto-generated profile, based on publicly available information

Peter S. Brzovic

Department of Biochemistry, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2014 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JPJonathan N Pruneda
Jonathan N Pruneda
FSF Donelson Smith
F Donelson Smith
ADAngela Daurie
Angela Daurie
DSDanielle L Swaney
Danielle L Swaney
JVJudit Villén
Judit Villén
PBPeter S Brzovic
Peter S Brzovic
Pathogenic bacteria introduce effector proteins directly into the cytosol of eukaryotic cells to promote invasion and colonization. OspG, a Shigella spp. effector kinase, plays a role in this process by helping to suppress the host inflammatory response. OspG has been reported to bind host E2 ubiquitin‐conjugating enzymes activated with ubiquitin (E2~Ub), a key enzyme complex in ubiquitin transfer pathways. A co‐crystal structure of the OspG/UbcH5c~Ub complex reveals that complex formation has important ramifications for the activity of both OspG and the UbcH5c~Ub conjugate. OspG is a minimal kinase domain containing only essential elements required for catalysis. UbcH5c~Ub binding stabilizes an active conformation of the kinase, greatly enhancing OspG kinase activity. In contrast, interaction with OspG stabilizes an extended, less reactive form of UbcH5c~Ub. Recognizing conserved E2 features, OspG can interact with at least ten distinct human E2s~Ub. Mouse oral infection studies indicate that E2~Ub conjugates act as novel regulators of OspG effector kinase function in eukaryotic host cells. See also: [MF de Jong & NM Alto][1] (January 2014) ![][2] The crystal structure of a complex between ubiquitin‐loaded UbcH5c and the Shigella effector kinase OspG shows how they regulate each other, and has allowed to demonstrate the role of this interaction in repressing host innate immune responses. EMBO Journal (2014) 33, 437–449 [1]: http://dx.doi.org/10.1002/embj.201387606 [2]: pending:yes

12 June 2023 in The EMBO Journal
Verified
Journal Article
Closed access
SWSamuel R Witus
Samuel R Witus
LTLisa M Tuttle
Lisa M Tuttle
Wenjing LiWenjing Li
Wenjing Li
AZAlex Zelter
Alex Zelter
MWMeiling Wang
Meiling Wang
RKRachel E Klevit
Rachel E Klevit

26 March 2022 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
SWSamuel R. Witus
Samuel R. Witus
Weixing ZhaoWeixing Zhao
Weixing Zhao
PBPeter S. Brzovic
Peter S. Brzovic
RKRachel E. Klevit
Rachel E. Klevit

1 January 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MCMatt J. Cook
Matt J. Cook
SDScott P. Delbecq
Scott P. Delbecq
TSThomas P. Schweppe
Thomas P. Schweppe
MGMiklos Guttman
Miklos Guttman
RKRachel E. Klevit
Rachel E. Klevit
PBPeter S. Brzovic
Peter S. Brzovic
SspH/IpaH bacterial effector E3 ubiquitin ligases, unrelated in sequence or structure to eukaryotic E3s, are utilized by a wide variety of gram-negative bacteria during pathogenesis. These E3s function in a eukaryotic environment, utilize host cell E2 ubiquitin-conjugating enzymes of the Ube2D family, and target host proteins for ubiquitylation. Despite several crystal structures, details of Ube2D~Ub binding and the mechanism of ubiquitin transfer are poorly understood. Here we show that the catalytic E3 ligase domain of SspH1 can be divided into two subdomains; an N-terminal subdomain that harbors the active site cysteine, and a C-terminal subdomain containing the Ube2D~Ub binding site. SspH1 mutations designed to restrict subdomain motions show rapid formation of an E3~Ub intermediate, but impaired Ub transfer to substrate. NMR experiments using paramagnetic spin labels reveal how SspH1 binds Ube2D~Ub and targets the E2~Ub active site. Unexpectedly, hydrogen/deuterium exchange mass spectrometry shows that the E2~Ub binding region is dynamic but stabilized in the E3~Ub intermediate. Our results support a model in which both subunits of an Ube2D~Ub clamp onto a dynamic region of SspH1 promoting an E3 conformation poised for transthiolation. A conformational change is then required for Ub transfer from E3~Ub to substrate.

15 July 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
WWWilliam Ryan Will
William Ryan Will
PBPeter Brzovic
Peter Brzovic
ITIsolde Le Trong
Isolde Le Trong
RSRonald E. Stenkamp
Ronald E. Stenkamp
MLMatthew B. Lawrenz
Matthew B. Lawrenz
FFFerric C. Fang
Ferric C. Fang
Gene duplication and subsequent evolutionary divergence have allowed conserved proteins to develop unique roles. The MarR family of transcription factors (TFs) has undergone extensive duplication and diversification in bacteria, where they act as environmentally-responsive repressors of genes encoding efflux pumps that confer resistance to xenobiotics, including many antimicrobial agents. We have performed structural, functional, and genetic analyses of representative members of the SlyA/RovA lineage of MarR TFs, which retain some ancestral functions, including repression of their own expression and that of divergently-transcribed multidrug efflux pumps, as well as allosteric inhibition by aromatic carboxylate compounds. However, SlyA and RovA have acquired the ability to counter-silence horizontally-acquired genes, which has greatly facilitated the evolution of Enterobacteriaceae by horizontal gene transfer. SlyA/RovA TFs in different species have independently evolved novel regulatory circuits to provide the enhanced levels of expression required for their new role. Moreover, in contrast to MarR, SlyA is not responsive to copper. These observations demonstrate the ability of TFs to acquire new functions as a result of evolutionary divergence of both cis -regulatory sequences and in trans interactions with modulatory ligands.

5 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TFTyler G. Franklin
Tyler G. Franklin
PBPeter S. Brzovic
Peter S. Brzovic
JPJonathan N. Pruneda
Jonathan N. Pruneda
HECT E3 ubiquitin (Ub) ligases direct their modified substrates toward a range of cellular fates dictated by the specific form of monomeric or polymeric Ub (polyUb) signal that is attached. How polyUb specificity is achieved has been a longstanding mystery, despite extensive study ranging from yeast to human. Two outlying examples of bacterial “HECT-like” (bHECT) E3 ligases have been reported in the human pathogens Enterohemorrhagic Escherichia coli and Salmonella Typhimurium, but what parallels can be drawn to eukaryotic HECT (eHECT) mechanism and specificity had not been explored. Here, we expanded the bHECT family and identified catalytically active, bona fide examples in both human and plant pathogens. By determining structures for three bHECT complexes in their primed, Ub-loaded states, we resolved key details of the full bHECT Ub ligation mechanism. One structure provided the first glimpse of a HECT E3 ligase in the act of ligating polyUb, yielding a means to rewire the polyUb specificity of both bHECT and eHECT ligases. Through studying this evolutionarily distinct bHECT family, we have not only gained insight into the function of key bacterial virulence factors but also revealed fundamental principles underlying HECT-type Ub ligation.